Effect of Agar Administration on Defecation and Fecal Condition in Chronic Constipated Patients
NCT ID: NCT02012543
Last Updated: 2014-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2013-11-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fecal Microbiota Transplantation for Chronic Functional Constipation
NCT03018613
Efficacy and Safety of Vibrating Capsule in Patients With Functional Constipation
NCT04671264
Defecation Function and Quality of Life in the Patients Treated With Surgery for Slow Transit Constipation
NCT04304183
Acupuncture for Chronic Constipation
NCT00746200
Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation
NCT00522093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At 0, 7th, 14th, 21th, and 28th day , the frequency of defecation and defecation condition is assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Agar jelly, constipation
Subjects eat a cap of agar jelly (180g) shortly before eating dinner every day for 4 weeks.
Agar jelly
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Agar jelly
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Showa Inan General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Akira Horiuchi
Chief, Digestive Disease Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Akira Horiuchi, MD
Role: PRINCIPAL_INVESTIGATOR
Showa Inan General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Showa Inan General Hospital
Komagane, Nagano, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kanten1
Identifier Type: OTHER
Identifier Source: secondary_id
Agar jelly
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.